Results 181 to 190 of about 138,715 (220)

The Past, Present, and Future Perspective of Photodynamic Therapy for Age-Related Macular Degeneration. [PDF]

J Clin Med
Honda S.
europepmc   +1 more source

Advances in the Study of Age-Related Macular Degeneration Based on Cell or Cell-Biomaterial Scaffolds. [PDF]

Bioengineering (Basel)
Li Z, Hu Z, Gao Z.
europepmc   +1 more source

Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers. [PDF]

Front Ophthalmol (Lausanne)
Hogan B, Mehta N, Caldwell AS, Marin AI, Gill ZS, Liske-Cervantes A, Mathias MT, Manoharan N, Palestine AG, Forest TEC, Mandava N, Lynch AM, Patnaik JL.   +12 more
europepmc   +1 more source

Recurrence of neovascular age-related macular degeneration after discontinuation of modified treat and extend treatment. [PDF]

Sci Rep
Lee J, Choi J, Yu SY, Kim K.
europepmc   +1 more source

Intravitreal Administration of Avacincaptad Pegol in a Nonhuman Primate Model of Dry Age-Related Macular Degeneration. [PDF]

Pharmacol Res Perspect
Fujii R, Matsushita M, Itani Y, Hama A, Natsume T, Takamatsu H.   +5 more
europepmc   +1 more source

Is Multiwavelength Photobiomodulation Effective and Safe for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis. [PDF]

Ophthalmol Ther
Chen KY, Lee HK, Chan HC, Chan CM.
europepmc   +1 more source

Potential Efficacy of Metformin for Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. [PDF]

Ophthalmol Sci
Huh MD, Le SN, O'Brien KS, Keenan JD, Stewart JM.   +4 more
europepmc   +1 more source

Life's Essential 8, Genetic Susceptibility, and the Risk of Age-Related Macular Degeneration: A Prospective Cohort Study. [PDF]

Invest Ophthalmol Vis Sci
Wang W, Ren R, Liu Y, Ye X, Zhang R, Xi L, Wang L, Zhang Y, Zhang Y, Wang D.   +9 more
europepmc   +1 more source

Efficacy and safety of brolucizumab every 6 weeks induction therapy for neovascular age-related macular degeneration. [PDF]

Sci Rep
Honda S, Maruyama-Inoue M, Otsuji T, Kyo A, Kobayashi Y, Yamamoto Y, Gomi F.   +6 more
europepmc   +1 more source